Financhill
Sell
49

ASTH Quote, Financials, Valuation and Earnings

Last price:
$38.9600
Seasonality move :
32.77%
Day range:
$38.7500 - $39.8350
52-week range:
$29.0800 - $63.2000
Dividend yield:
0%
P/E ratio:
30.15x
P/S ratio:
1.09x
P/B ratio:
2.54x
Volume:
208.9K
Avg. volume:
342.8K
1-year change:
7.87%
Market cap:
$1.8B
Revenue:
$1.4B
EPS (TTM):
$1.30

Analysts' Opinion

  • Consensus Rating
    Astrana Health has received a consensus rating of Buy. The company's average rating is a Buy based on 10 Buy ratings, 2 Hold ratings, and 0 Sell ratings.
  • Price Target Upside
    According to analysts' consensus price target of $62.1000, Astrana Health has an estimated upside of 58.42% from its current price of $39.2000.
  • Price Target Downside
    According to analysts, the lowest downside price target is $41.0000 representing 100% downside risk from its current price of $39.2000.

Fair Value

  • According to the consensus of 12 analysts, Astrana Health has 58.42% upside to fair value with a price target of $62.1000 per share.

ASTH vs. S&P 500

  • Over the past 5 trading days, Astrana Health has overperformed the S&P 500 by 8.57% suggesting its relative strength compared to the major market average is strong at this time.

Share Buyback

  • Astrana Health does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Astrana Health has grown year-over-year revenues for 11 quarters straight. In the most recent quarter Astrana Health reported revenues of $478.7M.

Earnings Growth

  • Astrana Health earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Astrana Health reported earnings per share of $0.33.
Enterprise value:
1.7B
EV / Invested capital:
--
Price / LTM sales:
1.09x
EV / EBIT:
14.72x
EV / Revenue:
0.98x
PEG ratio (5yr expected):
0.89x
EV / Free cash flow:
24.04x
Price / Operating cash flow:
26.79x
Enterprise value / EBITDA:
12.10x
Gross Profit (TTM):
$259.9M
Return On Assets:
5.41%
Net Income Margin (TTM):
3.63%
Return On Equity:
12.67%
Return On Invested Capital:
7.4%
Operating Margin:
5.94%
Trailing 12 Months Fiscal Quarters
Period Ending 2022-09-30 2023-09-30 2024-09-30 2023-09-30 2024-09-30
Income Statement
Revenue $1B $1.3B $1.7B $348.2M $478.7M
Gross Profit $181.6M $217.1M $259.9M $72.8M $73.5M
Operating Income $93.9M $101.1M $84.8M $39.1M $28.4M
EBITDA $78M $129.5M $138.8M $46.1M $42.9M
Diluted EPS $1.36 $0.97 $1.30 $0.47 $0.33
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Balance Sheet
Current Assets $366.7M $427.2M $443.6M $476.2M $597M
Total Assets $814.3M $871.3M $943.4M $1.1B $1.3B
Current Liabilities $131.5M $116.8M $156.2M $203M $312.9M
Total Liabilities $386.1M $339.5M $390.1M $457.6M $778.3M
Total Equity $428.1M $531.8M $553.3M $615.6M $507.1M
Total Debt $235.6M $183M $202.3M $209.2M $438.1M
Trailing 12 Months Fiscal Quarters
Period Ending 2022-09-30 2023-09-30 2024-09-30 2023-09-30 2024-09-30
Cash Flow Statement
Cash Flow Operations -$15M $133.9M $82.4M $15.4M $34M
Cash From Investing $18.8M -$40.9M -$170.5M -$34.9M -$8.1M
Cash From Financing -$24.5M -$2.7M $162.4M -$510K -$3.2M
Free Cash Flow -$39.9M $111.5M $69.9M $11.3M $31.7M
ASTH
Sector
Market Cap
$1.8B
$43.4M
Price % of 52-Week High
62.03%
48.26%
Dividend Yield
0%
0%
Shareholder Yield
-1.62%
-0.75%
1-Year Price Total Return
7.87%
-34.26%
Beta (5-Year)
1.204
0.749
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
99.15%
Growth streak:
0 years

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Technicals

8-day SMA
Buy
Level $37.1538
200-day SMA
Sell
Level $44.5541
Bollinger Bands (100)
Sell
Level 34.3099 - 54.7899
Chaikin Money Flow
Buy
Level 4M
20-day SMA
Buy
Level $36.9255
Relative Strength Index (RSI14)
Buy
Level 63.9509
ADX Line
Buy
Level 21.7705
Williams %R
Sell
Level -13.525
50-day SMA
Buy
Level $36.0247
MACD (12, 26)
Buy
Level 0.6258
25-day Aroon Oscillator
Buy
Level 88
On Balance Volume
Neutral
Level 23.6M

Financial Scores

Buy
Altman Z-Score (Annual)
Level (4.597)
Buy
CA Score (Annual)
Level (1.1118)
Sell
Beneish M-Score (Annual)
Level (-2.2085)
Buy
Momentum Score
Level (3)
Buy
Ohlson Score
Level (0.0646)
Buy
Piotroski F Score (Annual)
Level (6)
Sell
Quality Ratio Score
Level (4)
Buy
Fundamental Score
Level (7)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care cost-effectively. It is focused on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. Its operating segment is the healthcare delivery segment.

Stock Forecast FAQ

In the current month, ASTH has received 10 Buy ratings 2 Hold ratings, and 0 Sell ratings. The ASTH average analyst price target in the past 3 months is $62.1000.

  • Where Will Astrana Health Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Astrana Health share price will rise to $62.1000 per share over the next 12 months.

  • What Do Analysts Say About Astrana Health?

    Analysts are divided on their view about Astrana Health share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Astrana Health is a Sell and believe this share price will drop from its current level to $41.0000.

  • What Is Astrana Health's Price Target?

    The price target for Astrana Health over the next 1-year time period is forecast to be $62.1000 according to 12 Wall Street analysts, 10 of them rate the stock a Buy, 0 rate the stock a Sell, and 2 analysts rate the stock a Hold.

  • Is ASTH A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Astrana Health is a Buy. 10 of 12 analysts rate the stock a Buy at this time.

  • How Can I Buy Shares Of ASTH?

    You can purchase shares of Astrana Health via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Astrana Health shares.

  • What Is The Astrana Health Share Price Today?

    Astrana Health was last trading at $38.9600 per share. This represents the most recent stock quote for Astrana Health. Yesterday, Astrana Health closed at $39.2000 per share.

  • How To Buy Astrana Health Stock Online?

    In order to purchase Astrana Health stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is ORCL Stock a Buy Sell or Hold?
Is ORCL Stock a Buy Sell or Hold?

High-tech plays, nowadays, have shifted to the cloud. A laundry…

Is UPS High Dividend Safe?
Is UPS High Dividend Safe?

Although full-year profits dipped, Q4 2024 revenue inched up 1.5%…

Is Thermo Fisher Stock a Buy Sell or Hold?
Is Thermo Fisher Stock a Buy Sell or Hold?

Nowadays, a doctor doesn’t just look at you and prescribe…

Stock Ideas

Buy
62
Is AAPL Stock a Buy?

Market Cap: $3.6T
P/E Ratio: 40x

Buy
56
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Sell
46
Is MSFT Stock a Buy?

Market Cap: $3.1T
P/E Ratio: 35x

Alerts

Sell
2
WST alert for Feb 14

West Pharmaceutical Services [WST] is up 7.82% over the past day.

Sell
25
TTD alert for Feb 14

The Trade Desk [TTD] is down 2.14% over the past day.

Buy
100
BROS alert for Feb 14

Dutch Bros [BROS] is down 1.88% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock